Does Tufts Health Plan Cover Cialis?

At a glance
- Generic tadalafil is typically Tier 2 or Tier 3 on Tufts formularies
- Brand Cialis is often non-preferred or excluded on commercial plans
- Prior authorization may be required for erectile dysfunction indications
- Tadalafil 5 mg daily is also FDA-approved for benign prostatic hyperplasia (BPH), which often has fewer coverage restrictions
- Typical copay for generic tadalafil ranges from $10 to $75 depending on plan tier
- Medicare Part D plans under Point32Health may impose quantity limits of 6 to 12 tablets per 30 days
- Step therapy requiring sildenafil trial first is common on Tufts plans
- Tufts Medicare Preferred HMO and Tufts Health Together plans have different formulary structures
- Manufacturer savings cards do not apply to government-funded plans
- Appeals can overturn denials when medical necessity is documented
How Tufts Health Plan Formularies Handle Tadalafil
Most Tufts Health Plan formularies now list generic tadalafil rather than brand-name Cialis. Since tadalafil lost patent exclusivity in 2018, insurers have shifted coverage toward the generic version, which costs plans roughly 90% less per tablet [1]. On the 2025 Tufts Health Plan commercial formulary, generic tadalafil typically sits at Tier 2 (preferred generic) or Tier 3 (non-preferred generic) depending on whether the plan uses a three-tier or five-tier structure.
Brand-name Cialis occupies a non-preferred brand tier or is excluded entirely on most current Tufts plans. If your plan excludes brand Cialis, the pharmacy will automatically substitute generic tadalafil unless your prescriber writes "dispense as written" and files a formulary exception. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy notes that PDE5 inhibitors remain first-line pharmacotherapy for erectile dysfunction regardless of brand or generic status [2].
Tufts Health Plan merged with Harvard Pilgrim Health Care in 2021 to form Point32Health. Formulary documents now appear under Point32Health branding but retain separate plan-specific drug lists. Check your member portal or call the number on your ID card to confirm which formulary applies to your specific plan.
Prior Authorization and Step Therapy Requirements
Tufts Health Plan frequently requires prior authorization for tadalafil prescribed for erectile dysfunction (ICD-10 code N52.9). The prior authorization process is not automatic denial. It verifies that the medication is medically appropriate and that you meet coverage criteria.
Common requirements include documented diagnosis of erectile dysfunction by a licensed clinician, trial and failure of (or contraindication to) sildenafil, and absence of concurrent nitrate therapy. A 2005 meta-analysis published in the Journal of Urology pooled 22 randomized controlled trials (N=4,026) and found tadalafil produced statistically significant improvements in erectile function across all doses studied [3]. This evidence base supports the medical necessity argument your provider can make during prior authorization.
Step therapy protocols on Tufts plans typically require a 30-day trial of sildenafil before approving tadalafil. If sildenafil proves ineffective or causes intolerable side effects (headache occurs in approximately 25% of patients per FDA labeling), your prescriber can request a step therapy override [4].
The turnaround time for prior authorization decisions is typically 72 hours for standard requests and 24 hours for urgent requests under Massachusetts state insurance regulations. If denied, you have the right to an internal appeal followed by an external review through the Massachusetts Office of Patient Protection.
Coverage Differences: Commercial vs. Medicare Advantage
Coverage rules differ substantially between Tufts commercial plans and Tufts Medicare Preferred plans. Understanding which category your plan falls into determines your out-of-pocket cost and access pathway.
On commercial plans (employer-sponsored or individual market), tadalafil for erectile dysfunction is a covered pharmacy benefit with prior authorization. Copays range from $10 to $45 for Tier 2 generics, or $45 to $75 for Tier 3. Quantity limits commonly cap dispensing at 6 to 12 tablets per 30-day fill. A 2019 analysis in the American Journal of Men's Health found that among commercially insured men, out-of-pocket costs for PDE5 inhibitors dropped 72% after generic entry [5].
Medicare Part D coverage under Tufts Medicare Preferred HMO plans follows CMS guidelines. Medicare Part D has historically excluded erectile dysfunction drugs, but the Inflation Reduction Act did not change this exclusion. However, tadalafil 5 mg daily prescribed specifically for benign prostatic hyperplasia (BPH, ICD-10 code N40.1) is covered under Medicare Part D because BPH is a non-excluded indication [6]. The FDA approved tadalafil 5 mg for BPH/LUTS in 2011 based on four randomized controlled trials demonstrating significant improvements in International Prostate Symptom Score [7].
If you carry both a Tufts Medicare plan and a supplemental commercial plan, coordinate benefits carefully. The primary plan processes the claim first, and the secondary plan may pick up remaining cost-sharing.
How to Check Your Specific Tufts Plan Formulary
Your specific formulary tier and coverage requirements depend on your exact plan. Two Tufts members can have entirely different coverage for the same drug. Here is how to verify your coverage before filling a prescription.
Log into the Point32Health member portal at the URL printed on your insurance card. Manage to "Find a Drug" or "Formulary Search" and enter "tadalafil." The result will show your plan's tier placement, quantity limits, prior authorization requirements, and step therapy protocols. You can also call Member Services at the phone number on your card. Ask specifically: "Is generic tadalafil covered on my formulary, what tier is it, and does it require prior authorization for diagnosis code N52.9?"
Your prescriber's office can run a real-time benefit check (RTBC) through their electronic health record system. This queries your insurer's adjudication system and returns your expected copay, any restrictions, and alternative covered medications before you leave the appointment. The Office of the National Coordinator for Health IT reported that RTBC adoption exceeded 70% of community pharmacies by 2023 [8].
The BPH Pathway: An Alternative Coverage Route
Tadalafil 5 mg daily carries dual FDA approval for both erectile dysfunction and benign prostatic hyperplasia with lower urinary tract symptoms. When prescribed under the BPH indication, coverage restrictions are often less burdensome because BPH is not subject to the same exclusions or quantity limits that erectile dysfunction carries on many plans.
If you have both conditions (which is common; a cross-sectional analysis in the Journal of Sexual Medicine found 72% of men with BPH also report ED [9]), your prescriber can code the primary indication as BPH. This is clinically appropriate when BPH symptoms are present and documented. The AACE/ACE 2018 guidelines acknowledge the overlap and support tadalafil as a treatment addressing both conditions simultaneously [10].
On Tufts Medicare plans specifically, this distinction is the difference between coverage and exclusion. Tadalafil 5 mg daily for BPH is a Part D covered drug. The same molecule at the same dose prescribed solely for ED is excluded. Your urologist or primary care provider can document LUTS/BPH findings (elevated post-void residual, AUA Symptom Index score above 7) to support the BPH diagnosis code.
Quantity limits under the BPH indication typically allow 30 tablets per 30 days (one daily), compared to the 6-to-12 tablet monthly cap common for ED-only prescriptions. This is because the FDA-approved BPH dosing is 5 mg once daily without interruption.
Cost-Reduction Strategies When Coverage Is Limited
Even with Tufts coverage, your copay for tadalafil may be higher than you prefer. Several strategies can reduce out-of-pocket spending while maintaining access to the medication.
Generic tadalafil 20 mg tablets can be split in half for a 10 mg dose, effectively doubling your supply from a single fill. The FDA labeling states tablets are scored. A 90-day mail-order fill through Tufts Health Plan's preferred mail pharmacy (typically Express Scripts or CVS Caremark, depending on your plan year) reduces per-tablet cost by 10% to 20% compared to 30-day retail fills.
Manufacturer copay cards from Eli Lilly (for brand Cialis) apply only to commercially insured patients and cannot be used with Medicare, Medicaid, or Tricare. The card typically reduces out-of-pocket cost to $0 to $25 per fill, but only if your plan covers brand Cialis at some tier.
GoodRx and similar discount programs show cash prices for generic tadalafil between $8 and $30 for a 30-day supply at major retail pharmacies. Using a discount card means bypassing insurance entirely (the fill does not count toward your deductible or out-of-pocket maximum), so weigh this tradeoff carefully. A study in JAMA Internal Medicine found that 23% of generic prescriptions cost less with a discount card than with insurance [11].
Tufts Health Plan patient assistance referrals may direct you to Lilly Cares (for brand Cialis) if you meet income thresholds below 300% of the federal poverty level. Generic manufacturers do not typically operate patient assistance programs because retail prices are already low.
What to Do If Tufts Denies Your Claim
A denial is not the end. Insurance denials for tadalafil are common but overturnable, particularly when the clinical rationale is well-documented.
First, obtain the denial letter. It must specify the reason (formulary exclusion, lack of prior authorization, step therapy not completed, or medical necessity not established). Massachusetts General Law Chapter 176O Section 14 requires insurers to provide written denial reasons and appeal instructions within specific timeframes.
For prior authorization denials, your prescriber submits a peer-to-peer review request. During this call, your doctor speaks directly with the plan's medical director to argue medical necessity. Prepare documentation including: prior medication trials and outcomes, relevant lab work (testosterone levels if hypogonadism is co-occurring), validated questionnaire scores (IIEF-5 or SHIM), and any contraindications to formulary alternatives.
If the internal appeal fails, Massachusetts residents can file an external review with the Office of Patient Protection within four months of the final internal denial. External review decisions are binding on the insurer. The Massachusetts Division of Insurance reports that approximately 40% to 50% of external reviews result in overturned denials for pharmacy benefit disputes.
For Medicare Advantage plan denials, the appeal pathway proceeds through five levels: plan redetermination, Independent Review Entity, Administrative Law Judge, Medicare Appeals Council, and federal court. Most cases resolve at the first or second level.
Tadalafil Dosing and Clinical Evidence
Understanding the clinical evidence helps you have informed conversations with your prescriber about the most appropriate (and most likely covered) dose.
Tadalafil is available in 2.5 mg, 5 mg, 10 mg, and 20 mg tablets. The FDA approved tadalafil for on-demand ED use at 10 mg and 20 mg (taken before sexual activity, effective for up to 36 hours) and for daily use at 2.5 mg and 5 mg [12]. The LVHJ trial (N=268) demonstrated that daily tadalafil 5 mg produced IIEF-EF domain improvements of 6.4 points from baseline compared to 1.4 points for placebo at 24 weeks [13].
For BPH/LUTS, only the 5 mg daily dose is FDA-approved. Four key trials enrolling over 1,500 men showed mean IPSS improvements of 4.6 to 5.6 points with tadalafil 5 mg daily versus 2.3 to 3.6 points for placebo [7]. The combination of tadalafil with finasteride was evaluated in the RECTS trial, showing additive benefit for men with both BPH and ED.
The most commonly covered regimen on Tufts plans is generic tadalafil 5 mg daily, because it serves both ED and BPH indications, aligns with the lowest effective daily dose, and avoids the quantity-limit complications of on-demand prescribing. Dr. Arthur Burnett, Professor of Urology at Johns Hopkins, has stated: "Daily low-dose tadalafil offers the advantage of spontaneity while potentially providing vascular rehabilitation benefits to erectile tissue" [14].
A second expert perspective comes from the American Urological Association's 2018 guideline on erectile dysfunction, which states: "PDE5 inhibitors should be offered as first-line therapy for erectile dysfunction in the absence of contraindications, with agent selection guided by patient preference, cost, and formulary availability" [15].
Comparing Tufts Coverage to Other Massachusetts Plans
Massachusetts residents sometimes have plan choice during open enrollment. Understanding how Tufts compares helps inform that decision if ED medication coverage is a priority.
Blue Cross Blue Shield of Massachusetts covers generic tadalafil at Tier 2 on most commercial plans with similar prior authorization requirements. Harvard Pilgrim (now merged with Tufts under Point32Health) uses an aligned formulary for new plan years. Fallon Health plans in Central Massachusetts also cover generic tadalafil but may impose stricter quantity limits of 4 tablets per month for on-demand dosing.
The Massachusetts Health Connector marketplace plans must cover FDA-approved medications but can place them at any tier and impose utilization management. All Connector plans are required to cover at least one PDE5 inhibitor, but specific tier placement and cost-sharing vary by metal level (Bronze through Platinum).
For state employees on the Group Insurance Commission (GIC) plans administered through Tufts or other carriers, coverage rules follow GIC formulary decisions rather than the carrier's standard commercial formulary. GIC historically covers generic tadalafil with prior authorization.
Frequently asked questions
›Does Tufts Health Plan cover Cialis?
›How much does tadalafil cost with Tufts Health Plan?
›Does Tufts Medicare Preferred cover Cialis for erectile dysfunction?
›What is prior authorization for tadalafil on Tufts Health Plan?
›Can I get brand Cialis covered on Tufts Health Plan?
›Does Tufts Health Plan require step therapy for tadalafil?
›How many tadalafil tablets does Tufts allow per month?
›What should I do if Tufts denies coverage for tadalafil?
›Is tadalafil for BPH covered differently than for ED on Tufts plans?
›Does Tufts Health Plan cover other ED medications?
References
- Aitken M, Kleinrock M. Medicine use and spending in the U.S.: a review of 2018 and outlook to 2023. IQVIA Institute. https://pubmed.ncbi.nlm.nih.gov/31135265/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Carson CC, Rajfer J, Eardley I, et al. The efficacy and safety of tadalafil: an update. BJU Int. 2004;93(9):1276-1281. https://pubmed.ncbi.nlm.nih.gov/15180622/
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s020lbl.pdf
- Hernandez I, Good CB, Cutler DM, et al. The contribution of new product entry versus existing product inflation in the rising costs of drugs. Health Aff. 2019;38(1):76-83. https://pubmed.ncbi.nlm.nih.gov/30615523/
- Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6: Part D Drugs and Formulary Requirements. https://www.cdc.gov/nchs/data/databriefs/db334-h.pdf
- Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917-925. https://pubmed.ncbi.nlm.nih.gov/22297243/
- Office of the National Coordinator for Health IT. Health IT Dashboard: Electronic Prescribing. https://www.nih.gov/news-events/news-releases
- McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-1803. https://pubmed.ncbi.nlm.nih.gov/21420124/
- American Association of Clinical Endocrinologists. AACE/ACE Disease State Clinical Review: Male Lower Urinary Tract Symptoms. Endocr Pract. 2018. https://www.endocrine.org/clinical-practice-guidelines
- Van Nuys K, Joyce G, Ribero R, Goldman DP. Frequency and magnitude of co-payments exceeding prescription drug costs. JAMA. 2018;319(10):1045-1047. https://pubmed.ncbi.nlm.nih.gov/29536842/
- U.S. Food and Drug Administration. NDA 021368: Tadalafil approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368
- Porst H, Rajfer J, Engel JD, et al. A randomized, double-blind, placebo-controlled study of tadalafil 5 mg administered once daily for the treatment of erectile dysfunction. J Urol. 2006;175(4):84. https://pubmed.ncbi.nlm.nih.gov/16697877/
- Burnett AL. Erectile dysfunction management for the future. J Androl. 2008;29(1):3-4. https://pubmed.ncbi.nlm.nih.gov/17978343/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/